CCCTN registry data reinforce the message that DanGer Shock’s findings supporting MCS apply narrowly to patients studied.

The Society for Cardiovascular Angiography & Interventions (SCAI) is pleased to announce the publication of the Expert ...

The Society for Cardiovascular Angiography & Interventions (SCAI) is pleased to announce the publication of the Expert Consensus Statement on the Management of Patients with STEMI Referred for Primary ...

The following is a summary of "Bivalirudin vs Heparin Anticoagulation in STEMI: Confirmation of the BRIGHT-4 Results," published in the October 2024 issue of Cardiology by Stone et al. In the ...

The Society for Cardiovascular Angiography & Interventions (SCAI) is pleased to announce the publication of the Expert ...

A study of over 450,000 NSTEMI admissions reveals that diabetics face disparities in care, with less invasive treatment ...

ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug ...

Background Patients with suspected acute myocardial infarction (AMI) and stroke commonly present first to the ambulance service. Little is known about experiences of prehospital care which are ...

Myocardial Infarction, Cardiovascular Disease, Prevention, Challenges, Review Abdin, A. (2024) Myocardial Infarction and the Prevention Strategies Keeping it at Bay: A Narrative Review. Open Access ...